AGIO logo

Agios Pharmaceuticals, Inc. (AGIO)

Profile

Full Name

Agios Pharmaceuticals, Inc.

Ticker

NASDAQ: AGIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 24, 2013

Indexes

Not included

Website

http://www.agios.com

Employees

486

Key Details

Price

$39.05(-1.21%)

Market cap

$2.26B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$36.50M(+36.07% YoY)

Annual EPS

$11.64(+283.89% YoY)

PE ratio

3.47

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $39.05
    AGIO price is $39.05

    30-Day Relative Volume

    1.25
    AGIO 30-day relative volume is 1.25

    Price Performance

    Price Most recent change

    -1.21%
    AGIO price was down -1.21% on Jul 11, 2025

    Price YTD change

    +18.84%
    AGIO price is up +18.84% since January 1st

    Price 1-year change

    -12.03%
    AGIO price is down -12.03% year-on-year

    Price 3-year change

    +66.24%
    AGIO price is up +66.24% over the past 3 years

    Price Range

    Price All-time high

    $138.85
    AGIO price is currently -71.88% below its historical high of $138.85

    Price 3-year low

    $19.43
    AGIO price is currently +100.98% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.26B
    AGIO market capitalization is $2.26 billion

    Market cap 3-year change

    +75.64%
    AGIO market capitalization is up +75.64% over the past 3 years

    Market cap All-time high

    $5.73B
    AGIO market capitalization is currently -60.56% below its historical high of $5.73 billion

    Market cap sector rank

    83.47%
    AGIO market capitalization is higher than 83.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.83%
    AGIO shares outstanding is up +1.83% year-on-year

    Shares Outstanding 3-Year Change

    +5.65%
    AGIO shares outstanding is up +5.65% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.15
    AGIO beta is 1.15

    200-day SMA

    $37.25
    AGIO price is currently +4.82% above its 200-day simple moving average

    50-day SMA

    $32.50
    AGIO price is currently +20.16% above its 50-day simple moving average

    RSI

    70.00
    AGIO 14-day relative strength index is 70.00

    Volume

    1.25
    AGIO 30-day relative volume is 1.25

    ATR

    $1.49
    AGIO average true range is $1.49

    10-day Historical Volatility

    46.53%
    AGIO 10-day historical volatility is 46.53%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $36.50M
    AGIO annual revenue is $36.50 million

    Revenue Analysts estimate

    $43.75M
    AGIO annual revenue is currently -16.58% lower than the consensus analysts' forecast

    Revenue 1-year change

    +36.07%
    AGIO annual revenue is up +36.07% year-on-year

    Revenue Sector rank

    42.27%
    AGIO annual revenue is higher than 42.27% of companies in Healthcare sector

    EPS

    EPS

    $11.64
    AGIO annual earnings per share is $11.64

    EPS Analysts estimate

    -$7.14
    AGIO annual earnings per share is currently -263.06% lower than the consensus analysts' forecast

    EPS 1-year change

    +283.89%
    AGIO annual earnings per share is up +283.89% year-on-year

    EPS Sector rank

    98.42%
    AGIO annual earnings per share is higher than 98.42% of companies in Healthcare sector

    Profit

    Gross profit

    $32.33M
    AGIO annual gross profit is $32.33 million

    Gross margin

    88.59%
    AGIO annual gross profit margin is 88.59%

    Operating profit

    -$425.74M
    AGIO annual operating income is -$425.74 million

    Operating margin

    -1166.47%
    AGIO annual operating profit margin is -1166.47%

    Net income

    $673.73M
    AGIO annual net profit is $673.73 million

    Net margin

    -
    AGIO annual net profit margin value is unknown

    Expenses

    Total expenses

    $462.24M
    AGIO annual total expenses is $462.24 million

    Operating expenses

    $458.07M
    AGIO annual total operating expenses is $458.07 million

    Cost of goods sold

    $4.17M
    AGIO annual cost of goods sold is $4.17 million

    Selling, general & administrative expenses

    $156.78M
    AGIO annual SGA is $156.78 million

    Depreciation and amortization

    $5.65M
    AGIO annual depreciation & amortization is $5.65 million

    Interest expense

    -
    AGIO annual interest expense value is unknown

    Income tax

    $44.24M
    AGIO annual income tax is $44.24 million

    EBIT & EBITDA

    EBIT

    -$425.74M
    AGIO annual earnings before interest & taxes is -$425.74 million

    EBITDA

    -$420.08M
    AGIO annual EBITDA is -$420.08 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.66B
    AGIO annual total assets is $1.66 billion

    Non current assets

    $697.60M
    AGIO annual long term assets is $697.60 million

    Current assets

    $965.60M
    AGIO annual total current assets is $965.60 million

    Cash and cash equivalents

    $76.25M
    AGIO annual cash & cash equivalents is $76.25 million

    Accounts receivable

    $4.11M
    AGIO annual accounts receivable is $4.11 million

    Inventory

    $27.62M
    AGIO annual inventory is $27.62 million

    Liabilities

    Total liabilities

    $122.24M
    AGIO annual total liabilities is $122.24 million

    Long term liabilities

    $41.09M
    AGIO annual total long term liabilities is $41.09 million

    Current liabilities

    $81.16M
    AGIO annual total current liabilities is $81.16 million

    Accounts payable

    $16.64M
    AGIO annual accounts payable is $16.64 million

    Debt

    Total debt

    $56.99M
    AGIO annual total debt is $56.99 million

    Total debt 1-year change

    -20.85%
    AGIO annual total debt is down -20.85% year-on-year

    Long term debt

    $40.21M
    AGIO annual long term debt is $40.21 million

    Short term debt

    $16.78M
    AGIO annual short term debt is $16.78 million

    Equity & Capital

    Shareholders equity

    $1.54B
    AGIO annual stockholders equity is $1.54 billion

    Book value

    $1.54B
    AGIO annual book value is $1.54 billion

    Retained earnings

    -$148.92M
    AGIO annual retained earnings is -$148.92 million

    Working capital

    $884.44M
    AGIO annual working capital is $884.44 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$389.84M
    AGIO annual cash flow from operations is -$389.84 million

    Cash from operations 1-year change

    -31.68%
    AGIO annual cash flow from operations is down -31.68% year-on-year

    Cash from investing

    $363.44M
    AGIO annual cash flow from investing activities is $363.44 million

    Cash from investing 1-year change

    +51.7%
    AGIO annual cash flow from investing activities is up +51.7% year-on-year

    Cash from financing

    $14.44M
    AGIO annual cash flow from financing activities is $14.44 million

    Cash from financing 1-year change

    +165.82%
    AGIO annual cash flow from financing activities is up +165.82% year-on-year

    CAPEX

    CAPEX

    $1.69M
    AGIO annual capital expenditures is $1.69 million

    CAPEX 1-year change

    -90.89%
    AGIO annual capital expenditures is down -90.89% year-on-year

    Free Cash Flow

    Free cash flow

    -$391.53M
    AGIO annual free cash flow is -$391.53 million

    Free cash flow 1-year change

    -24.47%
    AGIO annual free cash flow is down -24.47% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    88.59%
    AGIO annual gross profit margin is 88.59%

    Operating margin

    -1166.47%
    AGIO annual operating profit margin is -1166.47%

    Net margin

    -
    AGIO annual net profit margin value is unknown

    ROA & ROE

    ROA

    51.82%
    AGIO annual return on assets is 51.82%

    ROE

    57.29%
    AGIO annual return on equity is 57.29%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    3.47
    AGIO price to earnings ratio is 3.47

    PE ratio Sector rank

    6.57%
    AGIO price to earnings ratio is higher than 6.57% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.54
    AGIO price to book ratio is 1.54

    PB ratio Sector rank

    48.64%
    AGIO price to book ratio is higher than 48.64% of companies in Healthcare sector

    PS Ratio

    PS ratio

    61.07
    AGIO price to sales ratio is 61.07

    PS ratio Sector rank

    92.49%
    AGIO price to sales ratio is higher than 92.49% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.24B
    AGIO enterprise value is $2.24 billion

    Enterprise value Sector rank

    82.58%
    AGIO enterprise value is higher than 82.58% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.14
    AGIO EV/EBITDA is -5.14

    EV/EBITDA Sector rank

    23.66%
    AGIO EV/EBITDA is higher than 23.66% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    11.90
    AGIO annual current ratio is 11.90

    Quick ratio

    11.56
    AGIO annual quick ratio is 11.56

    Leverage

    Debt to equity

    0.00
    AGIO annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    AGIO annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    AGIO piotroski f-score is 4

    Altman Z-Score

    10.79
    AGIO altman z-score is 10.79

    Analyst ratings

    Recent major analysts updates

    May 2, 25 Scotiabank
    Sector Outperform
    Feb 24, 25 HC Wainwright & Co.
    Buy
    Dec 18, 24 Cantor Fitzgerald
    Overweight
    Dec 10, 24 RBC Capital
    Outperform
    Dec 9, 24 Scotiabank
    Sector Outperform
    Nov 1, 24 Scotiabank
    Sector Outperform
    Oct 16, 24 Scotiabank
    Sector Outperform
    Sep 27, 24 Leerink Partners
    Market Perform
    Sep 20, 24 Cantor Fitzgerald
    Overweight
    Sep 19, 24 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with AGIO included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Stocks ready to break out
    • What is the ticker symbol for Agios Pharmaceuticals, Inc.?
    • Does Agios Pharmaceuticals, Inc. pay dividends?
    • What sector is Agios Pharmaceuticals, Inc. in?
    • What industry is Agios Pharmaceuticals, Inc. in?
    • What country is Agios Pharmaceuticals, Inc. based in?
    • When did Agios Pharmaceuticals, Inc. go public?
    • Is Agios Pharmaceuticals, Inc. in the S&P 500?
    • Is Agios Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Agios Pharmaceuticals, Inc. in the Dow Jones?
    • When was Agios Pharmaceuticals, Inc.'s last earnings report?
    • When does Agios Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Agios Pharmaceuticals, Inc.?

    The ticker symbol for Agios Pharmaceuticals, Inc. is NASDAQ:AGIO

    Does Agios Pharmaceuticals, Inc. pay dividends?

    No, Agios Pharmaceuticals, Inc. does not pay dividends

    What sector is Agios Pharmaceuticals, Inc. in?

    Agios Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Agios Pharmaceuticals, Inc. in?

    Agios Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Agios Pharmaceuticals, Inc. based in?

    Agios Pharmaceuticals, Inc. is headquartered in United States

    When did Agios Pharmaceuticals, Inc. go public?

    Agios Pharmaceuticals, Inc.'s initial public offering (IPO) was on July 24, 2013

    Is Agios Pharmaceuticals, Inc. in the S&P 500?

    No, Agios Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Agios Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Agios Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Agios Pharmaceuticals, Inc. in the Dow Jones?

    No, Agios Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Agios Pharmaceuticals, Inc.'s last earnings report?

    Agios Pharmaceuticals, Inc.'s most recent earnings report was on May 1, 2025

    When does Agios Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Agios Pharmaceuticals, Inc. is August 1, 2025
    On this page